The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of germline genetic testing criteria in early-onset kidney cancer.
 
Hong Truong
No Relationships to Disclose
 
Rania Sheikh
No Relationships to Disclose
 
Ritesh Kotecha
No Relationships to Disclose
 
Yelena Kemel
No Relationships to Disclose
 
Aliya Khurram
No Relationships to Disclose
 
Peter Reisz
No Relationships to Disclose
 
Andrew Thomas Lenis
No Relationships to Disclose
 
Vijai Joseph
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Chung-Han Lee
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Calithera Biosciences; Eisai
 
Darren R. Feldman
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Novartis; Seagen
Other Relationship - UpToDate
 
Martin H Voss
Stock and Other Ownership Interests - CellGenix (I)
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - AVEO; Calithera Biosciences; Corvus Pharmaceuticals; Eisai; Exelixis; Merck; Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
Other Relationship - Bristol-Myers Squibb
 
Jonathan Coleman
Travel, Accommodations, Expenses - Digital Angiography Reading Center (I)
Other Relationship - Steba Biotech
 
Paul Russo
No Relationships to Disclose
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Alimera Sciences (I); Allergan (I); Biomarin (I); Fortress Biotech (I); Genentech/Roche (I); Novartis (I); Optos (I); Regeneron (I); Regenxbio (I); Spark Therapeutics (I)
 
A. Ari Hakimi
No Relationships to Disclose
 
Robert J. Motzer
Consulting or Advisory Role - AstraZeneca; Eisai; EMD Serono; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Kenneth Offit
No Relationships to Disclose
 
Sujata Patil
No Relationships to Disclose
 
Maria Isabel Carlo
Consulting or Advisory Role - Pfizer
Other Relationship - Prostate Cancer Foundation; Robert Wood Johnson Foundation